Case Report: Re-Treatment With Lu-DOTATATE in Neuroendocrine Tumors
نویسندگان
چکیده
منابع مشابه
Ga-68 DOTATATE PET/CT in Neuroendocrine Tumors: Initial Experience
Introduction: Neuroendocrine tumors (NET) are a heterogeneous group of neoplasms, majority of which express somatostatin (SST) receptors. Recently, with the widespread use of positron emission tomography/computed tomography (PET/CT) and development of novel PET tracers like Ga-68 DOTA peptide which specifically bind to somatostatin receptors (SSTR), Ga-68 DOTA peptide PET/CT is used in manageme...
متن کاملPancreatic Neuroendocrine Tumors: Case Reports on Treatment
Pancreatic neuroendocrine tumors are relatively uncommon lesions that arise in the endocrine cells of the pancreas. There is variability in the molecular biology of these tumors, making them difficult to treat. Until recently, there have been few systemic treatment options. With the growing incidence of pNETs, multiple clinical trials are underway to determine the route of treatment that will b...
متن کاملNAMPT Inhibitor GMX1778 Enhances the Efficacy of 177Lu-DOTATATE Treatment of Neuroendocrine Tumors.
Neuroendocrine tumors (NETs) can be treated by peptide receptor radionuclide therapy using radiolabeled somatostatin analogs. However, the efficacy of such treatment is low and needs to be optimized. Our study evaluated the potential radiosensitizing effects of inhibition of nicotineamide phosphoribosyltransferase on 177Lu-DOTATATE treatment in a NET model. METHODS Nude mice xenografted with ...
متن کاملEfficacy of Galium-68 DOTATATE PET/CT in the Detection of Metastasis Rate of Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors
Objective(s): The aim of this study was to determine metastasis rate in patients with well-differentiated grade1 (G1) and grade 2 (G2) gastroenteropancreatic neuroendocrine tumors (GEP NETs) using the gallium-68 DOTATATE positron emission tomography/computed tomography (68Ga-DOTATATE PET/CT). This study was also targeted toward investigating the relationship of maximum...
متن کاملHypoglycemia in Tumors Outside the Pancreas with a Case Report
A patient with adenocarcinoma of the stomach and recurrent hypoglycemia is presented. The fasting blood sugar ranged from lOm/100,ml to 35mg/100 and the serum insuline levels ranged from 24 miU/ml to 42 miu/ml. The counterregulatory hormones(growth hormone, cortisol, adrenocorticotropin hormone) levels were within normal limits. No significant hepatic involvement was observed in isotopic live...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Frontiers in Endocrinology
سال: 2021
ISSN: 1664-2392
DOI: 10.3389/fendo.2021.676973